Overview

Dapagliflozin and Hepatic Glucose Metabolism

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
the aim of this study is to examine the role of autonomic nervous system in the increase in hepatic glucose production in response to glucosuria caused by inhibition of renal glucose uptake
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Dapagliflozin